alexa Multi-Drug Therapy Including Immune Checkpoint Inhibitors in Ovarian Cancer | OMICS International| Abstract
ISSN: 2476-2024

Diagnostic Pathology: Open Access
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Short Communication   
  • Diagn Pathol Open 4: 159,

Multi-Drug Therapy Including Immune Checkpoint Inhibitors in Ovarian Cancer

Hitomi Yamashita, Kentaro Nakayama* and Satoru Kyo
Department of Obstetrics and Gynecology, Shimane University School of Medicine, 6938501, Izumo, Japan
*Corresponding Author : Kentaro Nakayama, Shimane University School of Medicine, Enyacho 89-1, Izumo 6938501, Shimane, Japan, Tel: (+81) 853-20-2268, Email: [email protected]

Received Date: Dec 20, 2019 / Accepted Date: Jan 06, 2020 / Published Date: Jan 13, 2020


Ovarian cancer has the worst prognosis among gynecological cancers. Since only a few cases of ovarian cancer could be treated effectively with immune checkpoint inhibitor monotherapy, to improve the prognosis of ovarian cancer, multi-drug therapy including immune checkpoint inhibitors is necessary. In this short commentary, we highlight the need for studies on novel treatment strategies.

Keywords: Microsatellite instability; Ovarian cancer; Immune checkpoint inhibitor; Immunohistochemistry; Mismatch repair protein

Citation: Yamashita H, Nakayama K, Kyo S (2019) Multi-Drug Therapy Including Immune Checkpoint Inhibitors in Ovarian Cancer. Diagn Pathol Open 4: 159.

Copyright: © 2020 Yamashita H, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Select your language of interest to view the total content in your interested language

Post Your Comment Citation
Share This Article
Recommended Conferences

Euro-Global Summit on Probiotics

Zurich, Switzerland

World Congress on Histopathology & Cytopathology

Kyoto, Japan

18th Asia Pacific Pathology Congress

Tokyo, Japan
Article Usage
  • Total views: 105
  • [From(publication date): 0-0 - Apr 02, 2020]
  • Breakdown by view type
  • HTML page views: 86
  • PDF downloads: 19